2018Journal of Dermatological TreatmentRequires access

A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab

Simon Francis Thomsen

Open publisher page 4 citations

Abstract

"A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab." Journal of Dermatological Treatment, 29(8), pp. 823–824

About this research paper

What this paper is about

"A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab." Journal of Dermatological Treatment, 29(8), pp. 823–824

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

"A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab." Journal of Dermatological Treatment, 29(8), pp. 823–824

Key concepts: Hidradenitis suppurativa, Dermatology Life Quality Index, Medicine, Adalimumab, Dermatology, Quality of life (healthcare), Psoriasis, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab — Research Paper | ScholarLens